Your browser doesn't support javascript.
A one-year hospital-based prospective COVID-19 open-cohort in the Eastern Mediterranean region: The Khorshid COVID Cohort (KCC) study.
Sami, Ramin; Soltaninejad, Forogh; Amra, Babak; Naderi, Zohre; Haghjooy Javanmard, Shaghayegh; Iraj, Bijan; Haji Ahmadi, Somayeh; Shayganfar, Azin; Dehghan, Mehrnegar; Khademi, Nilufar; Sadat Hosseini, Nastaran; Mortazavi, Mojgan; Mansourian, Marjan; Mañanas, Miquel Angel; Marateb, Hamid Reza; Adibi, Peyman.
  • Sami R; Department of Internal Medicine, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Soltaninejad F; The Respiratory Research Center, Pulmonary Division, Department of Internal Medicine, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Amra B; Bamdad Respiratory Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Naderi Z; Department of Internal Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Haghjooy Javanmard S; Department of Physiology, School of Medicine, Applied Physiology Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Iraj B; Isfahan Endocrine and Metabolism Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Haji Ahmadi S; Department of Radiology, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Shayganfar A; Department of Radiology, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Dehghan M; School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Khademi N; School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Sadat Hosseini N; School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Mortazavi M; Isfahan Kidney Diseases Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Mansourian M; Department of Epidemiology and Biostatistics, School of Health, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Mañanas MA; Biomedical Engineering Research Centre (CREB), Automatic Control Department (ESAII), Universitat Politècnica de Catalunya-Barcelona Tech (UPC), Barcelona, Spain.
  • Marateb HR; Biomedical Engineering Research Centre (CREB), Automatic Control Department (ESAII), Universitat Politècnica de Catalunya-Barcelona Tech (UPC), Barcelona, Spain.
  • Adibi P; Biomedical Research Networking Center in Bioengineering, Biomaterials, and Nanomedicine (CIBER-BBN), Zaragoza, Spain.
PLoS One ; 15(11): e0241537, 2020.
Article in English | MEDLINE | ID: covidwho-914233
Preprint
This scientific journal article is probably based on a previously available preprint. It has been identified through a machine matching algorithm, human confirmation is still pending.
See preprint
ABSTRACT
The COVID-19 is rapidly scattering worldwide, and the number of cases in the Eastern Mediterranean Region is rising. Thus, there is a need for immediate targeted actions. We designed a longitudinal study in a hot outbreak zone to analyze the serial findings between infected patients for detecting temporal changes from February 2020. In a hospital-based open-cohort study, patients are followed from admission until one year from their discharge (the 1st, 4th, 12th weeks, and the first year). The patient recruitment phase finished at the end of August 2020, and the follow-up continues by the end of August 2021. The measurements included demographic, socio-economics, symptoms, health service diagnosis and treatment, contact history, and psychological variables. The signs improvement, death, length of stay in hospital were considered primary, and impaired pulmonary function and psychotic disorders were considered main secondary outcomes. Moreover, clinical symptoms and respiratory functions are being determined in such follow-ups. Among the first 600 COVID-19 cases, 490 patients with complete information (39% female; the average age of 57±15 years) were analyzed. Seven percent of these patients died. The three main leading causes of admission were fever (77%), dry cough (73%), and fatigue (69%). The most prevalent comorbidities between COVID-19 patients were hypertension (35%), diabetes (28%), and ischemic heart disease (14%). The percentage of primary composite endpoints (PCEP), defined as death, the use of mechanical ventilation, or admission to an intensive care unit was 18%. The Cox Proportional-Hazards Model for PCEP indicated the following significant risk factors Oxygen saturation < 80% (HR = 6.3; [CI 95% 2.5,15.5]), lymphopenia (HR = 3.5; [CI 95% 2.2,5.5]), Oxygen saturation 80%-90% (HR = 2.5; [CI 95% 1.1,5.8]), and thrombocytopenia (HR = 1.6; [CI 95% 1.1,2.5]). This long-term prospective Cohort may support healthcare professionals in the management of resources following this pandemic.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections Type of study: Cohort study / Observational study / Prognostic study Topics: Long Covid Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: English Journal: PLoS One Journal subject: Science / Medicine Year: 2020 Document Type: Article Affiliation country: Journal.pone.0241537

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections Type of study: Cohort study / Observational study / Prognostic study Topics: Long Covid Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: English Journal: PLoS One Journal subject: Science / Medicine Year: 2020 Document Type: Article Affiliation country: Journal.pone.0241537